Dis-Chem says employee strike cost it more than R75m
16 May 2019 - 07:55
byNick Hedley
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Dis-Chem says the strike resulted in direct costs of R50.4m, partly because of increased security and legal fees, and indirect costs of between R22.3m and R26m. Picture: FREDDY MAVUNDA
Dis-Chem Pharmacies says a strike by employees that lasted nearly five months shaved up to R76.4m off its profits in the year to end-February.
“Unfortunately, the industrial action which began mid-November last year heavily impacted the group’s performance,” CEO Ivan Saltzman said in a statement.
“The demands by the union were unreasonable considering the economic climate and the nature of the industry in which we operate.”
The retailer said on Thursday its headline earnings in the year rose 7.4% to R734.7m. The strike resulted in direct costs of R50.4m, partly because of increased security and legal costs, and indirect costs of between R22.3m and R26m, Dis-Chem said.
PODCAST: Behind the class action lawsuits against Tiger Brands
With the strike now over, the company is focused on developing “a productive employer-employee relationship, improving wholesale productivity levels and cost efficiency, as well as optimising the levels of stock-holding in the group, which the industrial action necessitated”.
“It is pleasing to continue to see market-share gains across all of our core categories,” Saltzman said.
Market-share gains were driven partly by the low prices and “aggressive promotional activity”.
The group declared a final dividend of 13.5c, from 12.8c previously.
Meanwhile, Dis-Chem said that in the 10 weeks to May 10 2019, group revenue grew by 12%.
Five stores had been added since the financial year-end and another 17 store openings were planned through to February 2020, it said.
Support our award-winning journalism. The Premium package (digital only) is R30 for the first month and thereafter you pay R129 p/m now ad-free for all subscribers.
Dis-Chem says employee strike cost it more than R75m
Dis-Chem Pharmacies says a strike by employees that lasted nearly five months shaved up to R76.4m off its profits in the year to end-February.
“Unfortunately, the industrial action which began mid-November last year heavily impacted the group’s performance,” CEO Ivan Saltzman said in a statement.
“The demands by the union were unreasonable considering the economic climate and the nature of the industry in which we operate.”
The retailer said on Thursday its headline earnings in the year rose 7.4% to R734.7m. The strike resulted in direct costs of R50.4m, partly because of increased security and legal costs, and indirect costs of between R22.3m and R26m, Dis-Chem said.
PODCAST: Behind the class action lawsuits against Tiger Brands
Subscribe: iono.fm | Spotify | Apple Podcasts | Pocket Cast | Player.fm
Group revenues grew 10% in the year to R21.4bn.
With the strike now over, the company is focused on developing “a productive employer-employee relationship, improving wholesale productivity levels and cost efficiency, as well as optimising the levels of stock-holding in the group, which the industrial action necessitated”.
“It is pleasing to continue to see market-share gains across all of our core categories,” Saltzman said.
Market-share gains were driven partly by the low prices and “aggressive promotional activity”.
The group declared a final dividend of 13.5c, from 12.8c previously.
Meanwhile, Dis-Chem said that in the 10 weeks to May 10 2019, group revenue grew by 12%.
Five stores had been added since the financial year-end and another 17 store openings were planned through to February 2020, it said.
hedleyn@businesslive.co.za
Employers turn to private primary healthcare plans in lieu of elusive NHI
Private label a tonic as Clicks bests Dis-Chem
Cipla Medpro invests in health tech company Brandmed
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Most Read
Related Articles
Measles could affect usage of vaccine for HPV-related cancers
JONATHAN BROOMBERG: Why Discovery Health has chosen the cancer treatment path ...
Adults advised to get vaccinated again in US measles outbreak
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.